LETROZOLE DEXCEL

Land: Israël

Taal: Engels

Bron: Ministry of Health

Werkstoffen:

LETROZOLE

Beschikbaar vanaf:

DEXCEL LTD, ISRAEL

ATC-code:

L02BG04

farmaceutische vorm:

FILM COATED TABLETS

Samenstelling:

LETROZOLE 2.5 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Therapeutische categorie:

LETROZOLE

Therapeutisch gebied:

LETROZOLE

therapeutische indicaties:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Autorisatie datum:

2016-02-29